Axinn Secures Antitrust Clearance for McKesson’s Transaction with Change Healthcare to Form $3.4 Billion New Health Care Information Technology Company
December 21, 2016
Axinn was antitrust counsel to McKesson Corporation, a leading global health care services and information technology company, in a transaction with Change Healthcare Holdings, Inc., a leading provider of software and analytics, network solutions and technology-enabled services, to create a new health care information technology company. The deal will combine substantially all of Change Healthcare’s business and the majority of McKesson Technology Solutions into a new company with $3.4 billion in pro forma combined total annual revenues for the fiscal year ended March 31, 2016.
The Axinn team secured unconditional antitrust clearance for the transaction after successfully navigating a more than six-month investigation by the Department of Justice, including a Second Request.
The Axinn team was led by Daniel Bitton, Jeny Maier, Russell Steinthal and Mike Keeley, assisted by Morris Bloom.
https://www.sec.gov/Archives/edgar/data/927653/000119312516701938/d220900d8k.htm
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Seven Axinn Attorneys Named to 2025 Capital Pro Bono Honor Roll
Pro Bono
Antitrust
Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of its Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Appoints Rachael Philbin as Chief Innovation Officer
News
Teva v. Lilly -- Clarifies Written Description of Method Claims Involving A Genus
Axinn Viewpoints
Intellectual Property
What’s Up? Competition Enforcement Updates From Italy and Portugal
Podcast
Antitrust
ACI 22nd Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
Antitrust Fault Lines: Will Licensing Negotiation Groups Reshape SEP Licensing?
Byline Articles
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Kenina Lee Selected as a Member of Law360’s 2026 Competition Editorial Advisory Board
Awards & Recognitions
Antitrust